BACKGROUND Although previous observational studies have documented late luminal enlargement and expansive remodeling following implantation of a bioresorbable vascular scaffold (BVS), no comparison with metallic stents has been conducted in a randomized fashion.
I ntravascular ultrasound (IVUS) has been instrumental in the understanding of the atherosclerotic process and in the development of coronary interventional cardiology (1) . Basically, IVUS defines 2 interfaces: 1) one between the flowing blood and the intima; and 2) one between the media and the adventitia. Therefore, multiple options of interaction exist among these 3 compartments, lumen, plaque-media, and adventitia. The relationship between lumen area (LA), plaque-media, and vessel area (VA) is the foundation of Glagov's principle of compensatory expansive remodeling of the external elastic membrane (2) . Considering the changes in these 3 compartments, there are, conceptually, 9 possibilities of expansive or constrictive remodeling, increase or decrease in plaque-media, and increase or decrease in LA (3) . Fundamental to atherosclerosis progression and regression, these interactions are also essential as vessel wall reactions to the transient barotrauma of balloon angioplasty (4-7) and the permanent or transient "scaffolding" effect of either metallic stents (8) or bioresorbable scaffolds (9) .
The advent of bioresorbable vascular scaffolds (BVS) has prompted us to analyze the short-and longterm effect of the bioresorbable scaffolds on vessel wall dynamics, including remodeling (10) . It has been hypothesized that the potential for remodeling should be more prominent than the remodeling observed with metallic stents and should lead to late lumen enlargement (11) . The ABSORB II trial did not meet its coprimary endpoints: superiority in vasomotion and noninferiority in angiographic late luminal loss following implantation of the Absorb drug-eluting BVS compared with the Xience metallic drug-eluting stent (DES) (Abbott Vascular, Santa Clara, California), but it has given us the opportunity to investigate, in the context of a randomized trial, the changes of long-term vessel wall morphometry after implantation of either bioresorbable scaffolds or metallic stents.
METHODS
The ABSORB II trial was a prospective, singleblind, multicenter clinical trial that randomized patients to percutaneous coronary intervention (PCI) with placement of either Absorb bioresorbable scaffolds or Xience metallic stents in a 2:1 fashion. The trial design, the study devices, and the inclusion and exclusion criteria have been described in detail previously (12, 13) . As mandated by the protocol, all The methods of quantitative IVUS have been previously published (1, 12 intrascaffold-stent neointima was included in the metric "plaque-media ¼ vessel area À lumen area."
The reference segments after device implantation were the 5-mm segments proximal and distal to the device. According to a previous study (14) , relative range of interobserver reproducibility of measurement for lumen, plaque-media, and vessel crosssectional areas based on 2 SD of their measurements Relative changes in vessel area (VA) (constrictive remodeling <À12%, expansive remodeling >þ12%) and relative changes in lumen area (LA) (lumen reduction <À15%, lumen enlargement >þ15%) defined remodeling patterns. No lesions showed constrictive remodeling with LA increase or expansive remodeling with LA decrease. Expansive vessel wall remodeling was more frequent with the bioresorbable vascular scaffold (BVS) than the metallic drug-eluting stent (DES) and could be determined by patient baseline characteristics and periprocedural factors. LDL ¼ low-density lipoprotein; PCI ¼ percutaneous coronary intervention.
Serruys et al. Vessel Remodeling in ABSORB II were AE15%, AE22%, and AE12%, respectively. Specifically, expansive remodeling was defined as a relative change in mean VA >þ12%, while constrictive remodeling was defined as a relative change in mean VA <À12%. According to these relative values of reproducibility, there were 9 theoretical patterns of vessel-lumen-plaque remodeling based on increase, no change, and decrease in each of the 3 parameters
The pre-procedure target ("to-be-scaffolded/ stented") segments were defined by coregistration with post-procedural IVUS using identical landmarks, such as side branches and calcium locations. Matching was done using dedicated software (IvusOCT-Registration, Division of Image Processing, Leiden, the Netherlands) (15) . Pre-procedural IVUS-VH analysis was performed within the target segments.
Tissue compositions, derived from pre-procedural IVUS-VH analysis, were expressed in percentages, averaged for multiple plaque-media cross-sectional areas, and related to the different patterns of remodeling at follow-up (16).
Pre-procedural offline or online qualitative comparative analysis (QCA) for the sizing of the device was mandatory. The strategy of device deployment, with or without post-dilation, is described in detail in the protocol as well as the various parameters involved in device deployment (Online Appendix). The maximal diameter of the device/post-dilation balloon throughout the procedure was used for calculation of various balloon-artery ratios, with reference lumen diameter defined either by IVUS using a circular model, as the average of 5-mm segments proximal and distal to the device segment (17) , or by QCA using the interpolated method (Online Table 1 ).
The definitions of expansion index, asymmetry index, eccentricity index, and deployment index are reported in the Online Appendix (15, (18) (19) (20) .
OVERALL SUBSTUDY OBJECTIVES. The primary objective of this study was to elucidate differences in remodeling patterns following BVS or DES implantation. First, differences in mean lumen, vessel, and plaque area changes were to be documented and the Table 2 ). The relative changes in mean VA, LA, and plaque-media area were significantly different for the 2 arms ( Figure 2) .
The relationship between relative changes in mean
LA and mean VA is illustrated in Figure 3 . 
Based on the boundaries of interobserver reproducibility of area measurements, we categorized 9 patterns of remodeling per relative changes in mean LA and mean VA (Central Illustration, Figure 3 ). The IVUS parameters post-procedure and at 3 years within each group are provided in Online Table 3 .
The lesion subset groups are labeled A through I ( Figure 3 ). In the BVS arm, groups B and C showed an increase in mean LA that was beyond interobserver reproducibility. In group B, the increase in mean LA was partially due to a small decrease in plaque-media area and plaque burden. Group C consisted of cases with late lumen enlargement associated with expansive remodeling that exceeded the increase in plaquemedia area, resulting in a plaque burden decrease. Table 4 and Serruys et al. Table 5 shows the result of univariate analysis for predictors of expansive remodeling. Subsequent multivariate analysis ( Vessel Remodeling in ABSORB II remodeling identified by the multivariate analysis, despite some trends that might become significant in a larger sample size population ( Figure 6 ).
DISCUSSION
In this study, the main findings were: 1) lesions treated with the BVS exhibited a larger increase in Table 2 ); however, the relationship between LA and plaque burden >40% was consistent with Glagov's theorem (Figure 7) . In our serial analysis, taking into Values are n (%). *Letters correspond to subset designations in Figure 3 . †Chi-square test. Tables 1 and 2 . In the era of balloon angioplasty, restenosis was caused mainly by constrictive remodeling (4) . In a study using serial IVUS after angioplasty or directional coronary atherectomy, expansive remodeling was observed up to 1 month, but luminal reduction prevailed from 1 to 6 months, mainly due to negative remodeling (5, 6) .
Abbreviations as in
Between 6 months and 5 years, most patients have luminal enlargement after balloon angioplasty (7) .
Bare-metal stents were found to prevent constrictive remodeling, but generated intrastent neointimal hyperplasia resulting in some cases of in-stent restenosis (8) . Antiproliferative drugeluting metallic stents are effective to reduce intrastent neointimal hyperplasia (21) . With Values are n or mean AE SD. *p value for analysis of variance (ANOVA). Table 1 . Drug-eluting bioresorbable scaffolds prevent constrictive remodeling in the first 6 months following implantation, but after the loss of their mechanical integrity, they allow expansive remodeling modulated by predictors described in the following text (23) (24) (25) .
In contrast to the current study, the mean LA observed by optical coherent tomography in ABSORB cohort B at 3 years was stable after the initial decrease at 6 months (10). However, due to the shorter penetration depth, optical coherent tomography could not evaluate VA and remodeling as IVUS was able to in this study.
PREDICTORS FOR EXPANSIVE REMODELING. In the present study, BVS implantation was an independent predictor for expansive remodeling. In previous observational studies, it has been documented that the mechanical support of scaffolds is lost 6 to 12 months after implantation (23) and that vessel and scaffold can potentially enlarge subsequently. In the preclinical study by Otsuka et al. Female sex was also an independent predictor for expansive remodeling in the current study. In an IVUS substudy of the WISE (Women's Ischemia Syndrome Evaluation) study, there was a high prevalence of atherosclerosis with positive remodeling and preserved lumen size (31) . Considering that estrogen has anti-inflammatory effects, the proinflammatory status after menopause might promote expansive remodeling (32) .
Among the balloon-artery ratios investigated, the ratio calculated with the expected balloon diameter There was no significant difference by device type for each determinant of expansive remodeling. PCI ¼ percutaneous coronary intervention; other abbreviations as in Figure 1 . Vessel Remodeling in ABSORB II had the best predictive value, probably because the parameter also incorporates the inflation pressure.
The expected balloon diameter concept has been appropriately criticized because this parameter was evaluated in vitro, in the absence of any constraining force, such as a calcified or fibrotic wall; however, in this study, the statistical analysis based on a sensitivity-specificity indicator led us to discover that an expected balloon-artery ratio >1.25 was an independent procedural parameter predicting an expansive remodeling process in a large-scale clinical study. A high balloon-artery ratio resulted in vascular injury, which has been reported to induce expansive remodeling (33) through macrophage infiltration and matrix metalloproteinase increase (34) . Also, the relationship between expansion index and vessel remodeling must rely on the same pathophysiological principle.
Higher LDL-C and necrotic core have previously been reported as predictors of expansive remodeling (35) (36) (37) . Higher LDL-C level can increase necrotic core, oxidize lipid pool in vessel walls, and induce inflammatory responses involving metalloproteinases that promote vessel enlargement (38, 39) . The concomitant presence of a pre-existing inflammatory process (necrotic core) and the inflammatory process specifically related to the bioabsorption of the polymer may lead to longer and stronger inflammation-inducing expansive remodeling (26, 40) . 
